Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT
- Status
- TERMINATED
- Phase
- PHASE2
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
- Status
- TERMINATED
- Phase
- NA
Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib, Rituximab and Combination Chemotherapy in Treating Participants With Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
ALL Adult Consortium Trial: Adult ALL Trial
- Status
- COMPLETED
- Phase
- PHASE2
Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2